Earnings
GLMD
3.889
-0.03%
-0.001
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
15.93M
59.56M
--
827.00K
--
--
226.00K
--
--
--
601.00K
112.00K
76.43M
709.00K
--
--
--
--
--
--
--
709.00K
77.14M
--
6.00M
0.00
--
--
--
--
--
--
--
--
--
935.00K
6.93M
0.00
--
--
--
352.00K
352.00K
7.29M
58.00K
176.70M
-106.94M
--
--
--
69.85M
69.85M
77.14M
FY 2018-12-31
24.16M
66.03M
--
--
--
--
51.00K
--
--
--
167.00K
--
90.41M
194.00K
--
--
--
--
--
--
--
194.00K
90.60M
--
1.81M
0.00
--
--
--
--
--
--
--
--
--
892.00K
2.71M
0.00
--
--
--
--
0.00
2.71M
58.00K
174.32M
-86.47M
--
--
--
87.89M
87.89M
90.60M
FY 2017-12-31
13.02M
5.98M
--
155.00K
--
--
0.00
--
--
--
--
--
19.15M
491.00K
--
--
--
--
--
--
--
491.00K
19.64M
--
2.28M
0.00
--
--
--
--
--
--
--
--
--
1.57M
3.85M
0.00
--
--
--
0.00
0.00
3.85M
40.00K
92.38M
-76.62M
--
--
--
15.79M
15.79M
19.64M
FY 2016-12-31
3.10M
12.35M
--
284.00K
--
--
0.00
--
--
--
--
--
15.73M
718.00K
--
--
--
--
--
--
--
718.00K
16.45M
--
3.12M
0.00
--
--
--
--
--
--
--
--
--
1.46M
4.58M
0.00
--
--
--
796.00K
796.00K
5.38M
34.00K
75.45M
-64.32M
--
--
--
11.07M
11.07M
16.45M
FY 2015-12-31
4.16M
18.84M
--
109.00K
--
--
109.00K
--
--
--
270.00K
--
23.38M
883.00K
--
--
--
--
--
--
--
883.00K
24.26M
--
2.26M
0.00
--
--
--
--
--
282.00K
--
--
--
--
2.54M
0.00
--
--
--
177.00K
177.00K
2.72M
32.00K
69.09M
-47.37M
--
--
--
21.55M
21.55M
24.26M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out GLMD latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Galmed Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.